切换至 "中华医学电子期刊资源库"

中华腔镜泌尿外科杂志(电子版) ›› 2020, Vol. 14 ›› Issue (03) : 166 -170. doi: 10.3877/cma.j.issn.1674-3253.2020.03.002

所属专题: 文献

临床研究

层面递进法激光腔内剜除高危前列腺增生的治疗体会
罗保华1, 李名钊2, 王华2, 冯华聪2, 谢耀东2, 刘小彭2,()   
  1. 1. 5180552 深圳,南方科技大学医院泌尿外科
    2. 510630 广州,中山大学附属第三医院泌尿外科
  • 收稿日期:2018-12-18 出版日期:2020-06-01
  • 通信作者: 刘小彭
  • 基金资助:
    广州市天河区科技计划项目医疗联合体项目(2018)

Experiences in the treatment of high-risk prostatic hyperplasia by laser intracavitary extirpation with hierarchical method

Baohua Luo1, Mingzhao Li2, Hua Wang2, Huacong Feng2, Yaodong Xie2, Xiaopeng Liu2,()   

  1. 1. Department of Urology, Hospital of Southern Univeristy of Science and Technology, Shenzhen 518055, China
    2. Department of Urology, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510630, China
  • Received:2018-12-18 Published:2020-06-01
  • Corresponding author: Xiaopeng Liu
  • About author:
    Corresponding author: Liu Xiaopeng, Email:
引用本文:

罗保华, 李名钊, 王华, 冯华聪, 谢耀东, 刘小彭. 层面递进法激光腔内剜除高危前列腺增生的治疗体会[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2020, 14(03): 166-170.

Baohua Luo, Mingzhao Li, Hua Wang, Huacong Feng, Yaodong Xie, Xiaopeng Liu. Experiences in the treatment of high-risk prostatic hyperplasia by laser intracavitary extirpation with hierarchical method[J/OL]. Chinese Journal of Endourology(Electronic Edition), 2020, 14(03): 166-170.

目的

探讨1 470 nm激光剜除治疗高危前列腺增生的手术技巧及临床效果。

方法

回顾分析2018年6月至2018年9月中山大学附属第三医院泌尿外科采用1 470 nm激光治疗共89例高危前列腺增生患者的临床资料,年龄平均(68±3)岁,前列腺体积(57.4±2.6)ml。所有患者均采用"寻找层面,先易后难,剜切结合"的层面递进法思路行激光腔内前列腺剜除术,比较患者术中及术后情况。

结果

89例均顺利完成手术,与术前相比,术后3个月患者最大尿流率明显增加,[(6.9±2.1) ml/s vs(19.8±3.6) ml/s]。国际前列腺症状评分显著好转,[(24.6±1.7) vs(8.0±1.2)]。术中无输血、无电切综合征、无直肠和膀胱穿孔病例,无输尿管损伤、大出血、心脑血管意外等严重并发症发生。

结论

层面递进法激光剜除技术构想对于高危前列腺增生外科包膜层面的寻找、减少术后并发症有独到优势,且易于掌握,或可为业界同行提供一个新的思路。

Objective

To investigate and evaluate the clinical effect and safety of intracavitary laser surgery with the hierarchical technique for high-risk prostate hyperplasia patients.

Methods

The modified surgery was performed on 89 cases of high risk prostate hyperplasia patients in the Third Affiliated Hospital of Sun Yet-Sen University. All the clinical data were analyzed retrospectively, The average age of the patient was (68±3) years, the average prostate volume was (57.4 ±2.6) ml. All patients underwent laser intracavitary prostate enucleation with the hierarchical approach, which is "Look for layers, easy first, difficult later, resect and enucleate", and their intraoperative and postoperative conditions were compared.

Results

All 89 procedures were performed successfully. The maximum urine flow rate (Qmax) were improved from (6.9±2.1) ml/s to (19.8±3.6) ml/s, and the international prostate symptom score (IPSS) were significantly decreased from (24.6±1.7) to (8.0±1.2), 3 months after surgery. No patient required transfusion. Transurethral resection syndrome, rectum and bladder perforation, and ureteral injury, massive bleeding, cardiovascular and cerebrovascular accidents and other serious complications were not occurred during the operation.

Conclusion

The laser exorsion surgery with hierarchical method has unique advantages in finding the capsule level and reducing postoperative complications of high-risk prostatic hyperplasia. It is easy to grasp and may provide a new method for colleagues.

表1 89例高危前列腺增生患者术前伴随症状及基础疾病分布情况
图1 层面递进法激光腔内剜除高危前列腺增生的手术步骤
表2 89例高危前列腺增生患者的临床资料
表3 患者手术前后评分比较(±s)
[1]
Van Assldonk B, Barkin J, Elteman DS. Medical theraphy for benign prostatic hyperplasia a review[J].Can J Urol, 2015, 22 (Suppl 1): 7-17.
[2]
Giiling PJ. Laser enucleation is increasingly becoming the standard of care for treatment of benign prostatic hyperplasia of all sizes[J]. Eur Urol, 2013, 63(5):868-871.
[3]
Elmansy HM, Kotb A, Elhilali MM.Holmium laser enucleation of the prostate:long-term durability of clinical outcomes and complication rates during 10 years of follow up [J]. J Urol, 2011, l86(5): 1972-1976.
[4]
杜传军, 白福鼎, 陈继民, 等. 前列腺钬激光剜出术与电切术安全性及疗效比较[J].中华泌尿外科杂志, 2004, 25(9): 627-630.
[5]
Johm M, David T. HoLEP: the gold standard for the surgical management of BPH in the 21st Century[J]. Am J Clin Exp Urol, 2O15, 3(1): 36-42.
[6]
Jin Chul Hwang, Sang Myung Park, Jong Bouk Lee. Holmium lase renucleation of the prostate for benign prostatic hyperplasia: effectiveness, safety, and overcoming of the learning curve[J]. Korean J Urol, 2010, 51(9): 619-624.
[7]
Seitz M, Ruszat R, Bayer T, et al. Exvivo and in vivo investigation of the novel 1 470 nm diode laser for potential treatment of benign prostatic enlargement[J]. Lasers Med Sci, 2009, 24(3): 419-424.
[8]
Shimizu Y, Hiraoka Y, Iwamoto K, et al. Measurement of residual adenoma after transurethral resection of the prostate by transurethral enucleation technique [J]. Urol Int, 2005, 74(2): 102-107.
[9]
刘春晓. 经尿道前列腺腔内剜除术[J/CD]. 中华腔镜泌尿外科杂志(电子版), 2009, 3(1): 54.
[10]
马明, 龚彬彬, 杨小荣, 等. 经尿道等离子剜除术与经尿道等离子电切术治疗良性前列腺增生的Meta分析[J]. 中国老年学杂志, 2017, 37(1): 145-147.
[11]
Hurle R, Vavassorl I, Piccineili A,et al.Holmium laser enucleation of the prostate combined with mechanical moreellation in 155 patients with benign prostatic hyperplasia [J]. Urol, 2002, 60(3): 449-453.
[12]
余闫宏, 安超, 齐书武, 等. 前列腺剜除术导致尿失禁的力学因素浅析[J]. 中国男科学杂志, 2016, 30(1): 34-37.
[13]
John M, David T. HoLEP: the gold standard for the surgical management of BPH in the 21st Century [J]. Am J Clin Exp Urol, 2015, 3(1): 36-42.
[14]
Wezel F, Wendt-Nordahl G, Huck N, et al. New alternatives for laser vaporization of the prostate: experimental evaluation of a 980-, 1 318- and 1 470 nm diode laser device [J]. World J Urol, 2010, 28(2): 181-186.
[15]
Gilling P J, WilsonI L C, King C J, et al, Long-term results of a randomized trial comparing holmium laser enucleation of the prostate: results at 7 years[J]. BJU Int, 2012, 109(3): 408-411.
[16]
Xu A, Zou Y, Li B, et al. A randomized trial comparing diode laser enucleation of the prostate with plasmakinetic enucleation and resection of the prostate for the treatment of benign prostatic hyperplasia [J]. J E ndourol, 2013, 27(10): 1254-1260.
[17]
Krambeck AE, Handa SE, Lingeman JE. Experience with more than 1 000 Holmium laser prostate enucleations for benign prostatic hyperplasia[J]. J Urol, 2013, 189(1 Suppl): S141-S145.
[18]
Lusuardi L, Mitterberger M, Hruby S, et al. Update on the use of diode laser in the management of benign prostate obstruction in 2014[J]. World J Urol, 2015, 33(4): 555-562.
[19]
谷猛, 陈其, 徐欢, 等. 钬激光剜除治疗前列腺增生术中保留控尿功能的技巧分析[J]. 现代泌尿外科杂志, 2016, 21(5): 349-352.
[20]
张浩, 司徒杰, 李名钊, 等. 侧入路4步法经尿道前列腺等离子解剖性剜除术治疗大体积前列腺增生[J/CD]. 中华腔镜泌尿外科杂志(电子版), 2016, 10(1): 5-7.
[1] 刘涛, 樊保佑, 史仲举, 刘德荣, 王沛. 股骨距是一个容易被误解的人体结构[J/OL]. 中华关节外科杂志(电子版), 2024, 18(05): 626-629.
[2] 吴晖, 佴永军, 施雪松, 魏晓为. 两种解剖入路下行直肠癌侧方淋巴结清扫的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 40-43.
[3] 胡森焱, 徐冬, 方健, 谢冬冬, 王财庆. ICG荧光显影Laennec膜入路腹腔镜解剖性肝切除的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 513-516.
[4] 林巧, 周丽. RFA联合LAH术治疗原发性肝癌并门静脉癌栓的临床效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 521-524.
[5] 戴朝六, 赵阳. 腹腔镜解剖性肝切除应该重视的几个问题[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 359-362.
[6] 刘连新, 孟凡征. 不断提高腹腔镜解剖性肝切除的规范化[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 355-358.
[7] 陆朝阳, 金也, 孙备. 腹腔镜解剖性肝切除的发展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 363-366.
[8] 刘炯, 彭乐, 马伟, 江斌. 鞘外解剖肝蒂技术治疗肝内胆管细胞癌的疗效评估[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 373-376.
[9] 吴登爽, 李墨农, 张欣红, 侯四川, 邱志磊. 解剖性显微镜下精索静脉结扎术的临床研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 591-596.
[10] 李想, 郭征, 田洪哲, 李杜, 熊梦瑶, 潘铁军. 1 470 nm半导体激光减容性切除治疗高危前列腺增生的临床研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 448-452.
[11] 程志刚, 魏辉, 李一波, 韩健, 钟永豪, 王铭, 张文辉, 周传东. 经尿道前列腺剜除术中保留前列腺分叶沟间组织对术后顺行射精功能的保护[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 453-458.
[12] 莫林键, 杨舒博, 农卫赟, 程继文. 人工智能虚拟数字医师在钬激光前列腺剜除日间手术患教管理中的应用[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(04): 318-322.
[13] 杨登科, 蔡明志, 张星星, 胡青, 郭大勇, 高喆, 毕永启, 胡伟. 腹腔镜膀胱颈Y-V成形术与经尿道膀胱颈电切治疗膀胱颈挛缩的比较[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(04): 392-396.
[14] 许桂祥, 徐丽, 赵鸿志, 周世龙, 武永明, 彭新刚. 腹腔镜视野下直疝疝囊进入阴囊的解剖观察及原因分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(04): 466-470.
[15] 刘颖斌, 陈炜. 胰腺全系膜切除理念存在的问题与争议[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 615-619.
阅读次数
全文


摘要